Close

VistaGen Therapeutics (VTGN) Receives Notice of Allowance for U.S. Patent Regarding Methods of Production for AV-101

September 28, 2017 8:06 AM EDT Send to a Friend
VistaGen Therapeutics Inc. (NASDAQ: VTGN), a clinical-stage biopharmaceutical company focused on developing new generation medicines for depression and other central ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login